Add as a preferred source on GoogleTwenty Healthcare Stocks Earn A+ EPS Revision Quant Grades Ahead of Q3
The group spans biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services and life sciences before third-quarter 2026 results.
Twenty healthcare companies received an A+ EPS Revision Quant Grade ahead of their third-quarter 2026 results, reflecting favorable changes in analysts’ earnings expectations.
The group includes Agilent Technologies, Amgen, Arcutis Biotherapeutics, Aveanna Healthcare Holdings and BrightSpring Health Services.
The names cover biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, patient care, healthcare facilities and life sciences. The broad mix places earnings revisions across several parts of the healthcare industry as the third-quarter reporting period approaches.
The stocks are drawing investor attention ahead of the third-quarter reporting period.
The companies are coming into focus as the third-quarter reporting season nears.
Enna Lee
ReporterEnna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.